Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Asthma and COPD market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Asthma and COPDmarket, defines the market attractiveness level of Asthma and COPD market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Asthma and COPD industry, describes the types of Asthma and COPD market, the applications of major players and the market size, and deeply analyzes the current situation of the global Asthma and COPD market and the development prospects and opportunities of Asthma and COPD industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Asthma and COPD market in Chapter 13.
By Player:
Merck
Roche Holding AG
Abbott Laboratories
Vectura Group
AstraZeneca
Teva Pharmaceutical Industries
Boehringer Ingelheim
Pfizer
GlaxoSmithKline
Novartis
By Type:
COPD
Asthma
By End-User:
Combination Products
Leukotriene Antagonists (LTA)
Inhaled Corticosteroids (ICS)
Anticholinergics
Short Acting Beta Agonists (SABA)
Long Acting Beta Agonists (LABA)
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Asthma and COPD Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Asthma and COPD Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Asthma and COPD Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Asthma and COPD Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Asthma and COPD Market Analysis and Outlook to 2022
-
7.1 Global Asthma and COPD Consumption (2017-2022)
-
7.2 United States Asthma and COPD Consumption (2017-2022)
-
7.3 Europe Asthma and COPD Consumption (2017-2022)
-
7.4 China Asthma and COPD Consumption (2017-2022)
-
7.5 Japan Asthma and COPD Consumption (2017-2022)
-
7.6 India Asthma and COPD Consumption (2017-2022)
-
7.7 South Korea Asthma and COPD Consumption (2017-2022)
8 Region and Country-wise Asthma and COPD Market Analysis and Outlook to 2028
-
8.1 Global Asthma and COPD Consumption Forecast (2022-2028)
-
8.2 United States Asthma and COPD Consumption Forecast (2022-2028)
-
8.3 Europe Asthma and COPD Consumption Forecast (2022-2028)
-
8.4 China Asthma and COPD Consumption Forecast (2022-2028)
-
8.5 Japan Asthma and COPD Consumption Forecast (2022-2028)
-
8.6 India Asthma and COPD Consumption Forecast (2022-2028)
-
8.7 South Korea Asthma and COPD Consumption Forecast (2022-2028)
9 Global Asthma and COPD Market Outlook by Types and Applications to 2022
-
9.1 Global Asthma and COPD Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global COPD Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Asthma Consumption and Growth Rate (2017-2022)
-
9.2 Global Asthma and COPD Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Combination Products Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Leukotriene Antagonists (LTA) Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Inhaled Corticosteroids (ICS) Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Anticholinergics Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Short Acting Beta Agonists (SABA) Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Long Acting Beta Agonists (LABA) Consumption and Growth Rate (2017-2022)
-
9.2.7 Global Others Consumption and Growth Rate (2017-2022)
10 Global Asthma and COPD Market Outlook by Types and Applications to 2028
-
10.1 Global Asthma and COPD Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global COPD Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Asthma Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Asthma and COPD Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Combination Products Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Leukotriene Antagonists (LTA) Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Inhaled Corticosteroids (ICS) Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Anticholinergics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Short Acting Beta Agonists (SABA) Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Long Acting Beta Agonists (LABA) Consumption Forecast and Growth Rate (2022-2028)
-
10.2.7 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Asthma and COPD Import and Export Analysis (Top 5 Countries)
-
11.1 Global Asthma and COPD Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Asthma and COPD Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Asthma and COPD Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Asthma and COPD Market Competitive Analysis
-
14.1 Merck
-
14.1.1 Merck Company Details
-
14.1.2 Merck Asthma and COPD Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Merck Asthma and COPD Product and Service
-
14.2 Roche Holding AG
-
14.2.1 Roche Holding AG Company Details
-
14.2.2 Roche Holding AG Asthma and COPD Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Roche Holding AG Asthma and COPD Product and Service
-
14.3 Abbott Laboratories
-
14.3.1 Abbott Laboratories Company Details
-
14.3.2 Abbott Laboratories Asthma and COPD Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Abbott Laboratories Asthma and COPD Product and Service
-
14.4 Vectura Group
-
14.4.1 Vectura Group Company Details
-
14.4.2 Vectura Group Asthma and COPD Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Vectura Group Asthma and COPD Product and Service
-
14.5 AstraZeneca
-
14.5.1 AstraZeneca Company Details
-
14.5.2 AstraZeneca Asthma and COPD Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 AstraZeneca Asthma and COPD Product and Service
-
14.6 Teva Pharmaceutical Industries
-
14.6.1 Teva Pharmaceutical Industries Company Details
-
14.6.2 Teva Pharmaceutical Industries Asthma and COPD Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Teva Pharmaceutical Industries Asthma and COPD Product and Service
-
14.7 Boehringer Ingelheim
-
14.7.1 Boehringer Ingelheim Company Details
-
14.7.2 Boehringer Ingelheim Asthma and COPD Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Boehringer Ingelheim Asthma and COPD Product and Service
-
14.8 Pfizer
-
14.8.1 Pfizer Company Details
-
14.8.2 Pfizer Asthma and COPD Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Pfizer Asthma and COPD Product and Service
-
14.9 GlaxoSmithKline
-
14.9.1 GlaxoSmithKline Company Details
-
14.9.2 GlaxoSmithKline Asthma and COPD Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 GlaxoSmithKline Asthma and COPD Product and Service
-
14.10 Novartis
-
14.10.1 Novartis Company Details
-
14.10.2 Novartis Asthma and COPD Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Novartis Asthma and COPD Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Asthma and COPD
-
Figure Asthma and COPD Picture
-
Table Global Asthma and COPD Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Asthma and COPD Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Asthma and COPD Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Asthma and COPD Consumption by Country (2017-2022)
-
Figure United States Asthma and COPD Consumption and Growth Rate (2017-2022)
-
Table Europe Asthma and COPD Consumption and Growth Rate (2017-2022)
-
Figure China Asthma and COPD Consumption and Growth Rate (2017-2022)
-
Figure Japan Asthma and COPD Consumption and Growth Rate (2017-2022)
-
Figure India Asthma and COPD Consumption and Growth Rate (2017-2022)
-
Figure South Korea Asthma and COPD Consumption and Growth Rate (2017-2022)
-
Figure Global Asthma and COPD Consumption Forecast by Country (2022-2028)
-
Figure United States Asthma and COPD Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Asthma and COPD Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Asthma and COPD Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Asthma and COPD Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Asthma and COPD Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Asthma and COPD Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global COPD Consumption and Growth Rate (2017-2022)
-
Figure Global Asthma Consumption and Growth Rate (2017-2022)
-
Figure Global Combination Products Consumption and Growth Rate (2017-2022)
-
Figure Global Leukotriene Antagonists (LTA) Consumption and Growth Rate (2017-2022)
-
Figure Global Inhaled Corticosteroids (ICS) Consumption and Growth Rate (2017-2022)
-
Figure Global Anticholinergics Consumption and Growth Rate (2017-2022)
-
Figure Global Short Acting Beta Agonists (SABA) Consumption and Growth Rate (2017-2022)
-
Figure Global Long Acting Beta Agonists (LABA) Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global COPD Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Asthma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Combination Products Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Leukotriene Antagonists (LTA) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Inhaled Corticosteroids (ICS) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anticholinergics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Short Acting Beta Agonists (SABA) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Long Acting Beta Agonists (LABA) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Asthma and COPD Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Asthma and COPD Export by Region (Top 5 Countries) (2017-2028)
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Asthma and COPD Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Asthma and COPD Product and Service
-
Table Roche Holding AG (Foundation Year, Company Profile and etc.)
-
Table Roche Holding AG Asthma and COPD Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Holding AG Asthma and COPD Product and Service
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories Asthma and COPD Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Asthma and COPD Product and Service
-
Table Vectura Group (Foundation Year, Company Profile and etc.)
-
Table Vectura Group Asthma and COPD Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vectura Group Asthma and COPD Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Asthma and COPD Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Asthma and COPD Product and Service
-
Table Teva Pharmaceutical Industries (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Industries Asthma and COPD Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Industries Asthma and COPD Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Asthma and COPD Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Asthma and COPD Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Asthma and COPD Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Asthma and COPD Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Asthma and COPD Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Asthma and COPD Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Asthma and COPD Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Asthma and COPD Product and Service
-
